Purity (HPLC)：≥98.0% (Research grade ≥98.0%, pharmacopoeial grade ≥99.0%)
Loss on Drying：≤1.0%
Acetate Content：In accordance with theoretical value (~11.0–12.0%)
Related Substances：Single impurity ≤1.0%, total impurities ≤2.0%
Water Content：≤3.0%
pH (1% Aqueous Solution/Suspension)：4.5–6.5
Appearance：White to off-white powder, conforms to standard
Identification (HPLC/MS)：Consistent with reference standard, qualified
-
Core Medical Application
Gonadotropin-releasing hormone (GnRH) agonist, used for palliative treatment of advanced prostate cancer, endometriosis, uterine fibroids, central precocious puberty, and endocrine therapy for premenopausal/estrogen receptor-positive breast cancer. Clinically formulated as long-acting injections (microspheres/implants) with administration intervals of 1–6 months.
-
Research & Reagent Application
As peptide API/biochemical reagent, used for hormonal regulation mechanism research, GnRH receptor function validation, endocrine disease animal model construction, and drug screening.
-
Other Applications
In veterinary medicine for animal reproductive control (e.g., estrus suppression, reproductive efficiency improvement); in assisted reproduction for hormone level regulation.
...
Product
